Ledger.Open graph →
SEC Form D · filed May 30, 2018

Cidara Therapeutics, Inc

Offering
$1.9M
Sold
$1.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Scott M. Rocklage · San Diego, CADirectorTaylor R. Sandison · San Diego, CAExecTheodore R. Schroeder · San Diego, CADirectorMatthew R. Onaitis · San Diego, CAExecJeffrey Stein · San Diego, CAExec · DirectorRobert J. Perez · San Diego, CADirectorDaniel D. Burgess · San Diego, CADirectorTimothy R. Franson · San Diego, CADirectorChrysa R. Mineo · San Diego, CADirectorBob Kerrey · Boston, MAExecKim Bishop · Grand Cayman, Cayman IslandsDirectorThane Wettig · Boston, MADirectorGino Santini · Boston, MAExecKurt Graves · Boston, MADirectorCorey M. Steffek · Boston, MAExec · DirectorPaul Feldman · Boston, MADirectorJeff Lebrun · Seattle, WADirectorHunt Stookey · FARMINGTON HILLS, MIDirectorKeith Crandell · Boston, MAExec · DirectorGlynn Bloomquist · AUSTIN, TXDirectorIan Charles · FARMINGTON HILLS, MIDirectorThomas L. Croft · DARTMOUTH, Nova Scotia, CanadaDirectorCameron W. Mcrae · Dartmouth, Nova Scotia, CanadaDirectorJames Pflaging · Denver, COExecAndrew Funk · Denver, COExecKarla Bodden · GEORGE TOWN, GRAND CAYMAN, Cayman IslandsDirectorMichael D. Weiss · New York City, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗